[HTML][HTML] SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica, M Merli… - BMC Infectious …, 2021 - Springer
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica, M Merli… - BMC INFECTIOUS …, 2021 - air.unimi.it
Background: Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica… - BMC infectious …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

[HTML][HTML] SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica, M Merli… - BMC Infectious …, 2021 - ncbi.nlm.nih.gov
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica, M Merli… - BMC INFECTIOUS …, 2021 - boa.unimib.it
Background: Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica… - BMC INFECTIOUS …, 2021 - iris.hunimed.eu
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional
proof-of-concept study IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste IT …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study.

L Colagrossi, M Antonello, S Renica, M Merli… - BMC Infectious …, 2021 - go.gale.com
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

[HTML][HTML] SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello… - BMC Infectious …, 2021 - bmcinfectdis.biomedcentral.com
Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated with worse
COVID-19 outcome. However, whether specific population can be at higher risk of viremia …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica… - BMC Infectious …, 2021 - search.proquest.com
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study.

L Colagrossi, M Antonello, S Renica, M Merli… - BMC Infectious …, 2021 - europepmc.org
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …